» Articles » PMID: 27485920

Analysis of Adaptive Mutations Selected During the Consecutive Passages of Hepatitis E Virus Produced from an Infectious CDNA Clone

Overview
Journal Virus Res
Specialty Microbiology
Date 2016 Aug 4
PMID 27485920
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

To characterize the genomic mutations of hepatitis E virus (HEV) during consecutive passages associated with adaptation to growth in cell culture, a cloned genotype 3 HEV [pJE03-1760F/wt, starting virus (SV)] was passaged 10 times in A549 cells, and the entire genomic sequence of the passage 10 (P10) progeny was determined. Compared to SV, P10 virus possessed two non-synonymous (T2808C and A5054G) and four synonymous mutations (C1213T, T2557C, C3118T and C4435T) in the ORF1. Full-length infectious cDNA clones with a single, double (T2808C and A5054G), or all six mutations, identical to P10, were constructed, and their replication capacity was compared. Four (C1213T, T2557C, T2808C and A5054G) of the six viruses with a single mutation grew more efficiently than SV. The P10 virus propagated more rapidly and grew more efficiently than SV and T2808C+A5054G and reached a higher viral load (95.1- and 8.5-fold, respectively) at 20days post-inoculation. An immunofluorescence analysis revealed that a high percentage (>80%) of cells inoculated with the P10 virus expressed ORF2 proteins, while relatively low percentages (nearly 30% or 5%) inoculated with T2808C+A5054G or SV, respectively, expressed ORF2 proteins. We found that not only non-synonymous but also synonymous HEV mutations are independently associated with increased virus production.

Citing Articles

Three Distinct Reporter Systems of Hepatitis E Virus and Their Utility as Drug Screening Platforms.

Primadharsini P, Nagashima S, Nishiyama T, Okamoto H Viruses. 2023; 15(10).

PMID: 37896767 PMC: 10611241. DOI: 10.3390/v15101989.


Development of a HiBiT-tagged reporter hepatitis E virus and its utility as an antiviral drug screening platform.

Nagashima S, Primadharsini P, Nishiyama T, Takahashi M, Murata K, Okamoto H J Virol. 2023; 97(9):e0050823.

PMID: 37681960 PMC: 10537679. DOI: 10.1128/jvi.00508-23.


Infection Dynamics and Genomic Mutations of Hepatitis E Virus in Naturally Infected Pigs on a Farrow-to-Finish Farm in Japan: A Survey from 2012 to 2021.

Takahashi M, Kunita S, Nishizawa T, Ohnishi H, Primadharsini P, Nagashima S Viruses. 2023; 15(7).

PMID: 37515202 PMC: 10385168. DOI: 10.3390/v15071516.


Development and Characterization of Efficient Cell Culture Systems for Genotype 1 Hepatitis E Virus and Its Infectious cDNA Clone.

Primadharsini P, Nagashima S, Tanaka T, Jirintai S, Takahashi M, Murata K Viruses. 2023; 15(4).

PMID: 37112827 PMC: 10146093. DOI: 10.3390/v15040845.


Development of Recombinant Infectious Hepatitis E Virus Harboring the nanoKAZ Gene and Its Application in Drug Screening.

Primadharsini P, Nagashima S, Nishiyama T, Takahashi M, Murata K, Okamoto H J Virol. 2022; 96(6):e0190621.

PMID: 35107380 PMC: 8941883. DOI: 10.1128/jvi.01906-21.